Healthcare

(OTC: CYDY) Three Additional Patients with Severe COVID-19 Treated with Leronlimab in New York Medical Center Bringing the Total to 10 Patients

VANCOUVER, Washington, Mar 30, 2020 — CytoDyn Inc. (otc.qb:CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that an […]

No Picture
Trading Ideas

3 Under-The-Radar Dividend Stocks With Over 8% Dividend Yield

What’s the most important investment metric an investor can focus on in the midst of a downturn? My vote is cash flow. It’s actually a great thing to track during any economic cycle – it just becomes especially important when a firm’s sales and profits head south when the business climate turns turbulent.Don’t just take my word for it. A quote attributed to market guru Michael Mauboussin is that “great fundamental investors focus on understanding the magnitude and sustainability of free cash flow.”Income-minded investors, such as retirees looking to supplement their social security checks with, could have some real opportunities …read more […]

No Picture
Trading Ideas

J&J to start human testing of coronavirus vaccine by September

J&J also committed more than $1 billion of investment along with U.S. agency Biomedical Advanced Research and Development Authority (BARDA) to co-fund vaccine research, expanding a previous collaboration. A patient was dosed with Moderna Inc’s vaccine in an early-stage trial earlier this month, making it the front-runner in the race to develop a viable vaccine. J&J said in January it had begun working on a possible vaccine for the coronavirus, using the same technologies used to make its experimental Ebola vaccine. …read more […]